Cargando…
Characterizing the Occurrence of Key Clinical Milestones in Duchenne Muscular Dystrophy in the United States Using Real-World Data
BACKGROUND: Data on the clinical course of Duchenne muscular dystrophy (DMD) exist from well-characterized clinical cohorts but estimates from real-world populations are fewer. OBJECTIVE: The objective was to estimate the prevalence of key clinical milestones by age, among real-world commercially-in...
Autores principales: | Szabo, Shelagh M., Klimchak, Alexa C., Qian, Christina, Iannaccone, Susan, Popoff, Evan, Gooch, Katherine L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697036/ https://www.ncbi.nlm.nih.gov/pubmed/36245384 http://dx.doi.org/10.3233/JND-220816 |
Ejemplares similares
-
Characterizing demographics, comorbidities, and costs of care among populations with Duchenne muscular dystrophy with Medicaid and commercial coverage
por: Klimchak, Alexa C, et al.
Publicado: (2021) -
Characterizing health state utilities associated with Duchenne muscular dystrophy: a systematic review
por: Szabo, Shelagh M., et al.
Publicado: (2019) -
Early Gross Motor Milestones in Duchenne Muscular Dystrophy
por: Norcia, Giulia, et al.
Publicado: (2021) -
The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review
por: Szabo, Shelagh M., et al.
Publicado: (2021) -
Exploring the relationship between North Star Ambulatory Assessment and Health Utilities Index scores in Duchenne muscular dystrophy
por: Audhya, Ivana, et al.
Publicado: (2023)